Texas A&M and Celltex Partnering on a Stem Cell-related Alzheimer’s Treatment

Texas A&M and Celltex Partnering on a Stem Cell-related Alzheimer’s Treatment
Texas A&M's Institute for Regenerative Medicine  and Celltex Therapeutics are teaming up to evaluate whether inflammation-fighting sacs that stem cells release could be used to treat Alzheimer’s. The fluid-filled sacs, which scientists call vesicles, transport material inside a cell. But cells often release them, and when this happens, they are called exosomes. Researchers at Texas A&M and Celltex plans a multiyear study on whether inflammation-fighting mesenchymal stem cell exosomes can be used to treat Alzheimer's. Mesenchymal stem cells can develop into almost any type of cell in the body, including bone, cartilage, muscle and fat. The initial studies will involve animals, but the goal is to have clinical trials in humans within three years. Exosomes are found in many body fluids, including blood and urine. They have specialized functions, including playing a key role in cell-to-cell signaling. These specialty roles give them great potential as therapies, including delivering anti-inflammatory agents to the brain. “We are hopeful that this research might someday treat the disease [Alzheimer's] effectively by stopping or delaying the neuronal [nerve cell] damage," Dr. Ashok K. Shetty, associate director of the Institute for Regenerative Medicine, said in a Texas A&M news story. "Alternatively, exosomes may rejuvenate the networks of surviving but sick neurons via a
Subscribe or to access all post and page content.

One comment

  1. Michele says:

    Anything to find a cure or satisfactorily pause Alzheimer’s. I would like to see a study with CBD oil for Alzheimer’s as well as ALS.

Leave a Comment

Your email address will not be published. Required fields are marked *